Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Macitentan for Vasospastic Angina: Proof-of-Concept Study
2018-002623-42Phase 4Completed
- Sponsor
- Academic Medical Center
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of macitentan in Coronary vasospasm (CAS), epicardial coronary artery spasm, Coronary Small Vessel Disease (CMD) and 1 more, sponsored by Academic Medical Center. Primary endpoint: Burden of anginal complaints. Started Feb 2019; status: completed.
02
Drugs
macitentan
03
Conditions
Coronary vasospasm (CAS)epicardial coronary artery spasmCoronary Small Vessel Disease (CMD)angina pectoris
Beyond the preview
Go deeper on 2018-002623-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-002623-42.